ArticleEuropean journal of hospital pharmacy : science and practice2019

Hospital admissions for bleeding events associated with treatment with apixaban, dabigatran and rivaroxaban.

José Luis Marco Garbayo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.